• Wednesday, August 1, 2018 @ 12:00 am

Geneva, Switzerland and Boston, MA - July 31, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy, today announced that it will release its second quarter 2018 financial results on Wednesday, August 8, 2018. ObsEva management will host an investment community conference call at 8 a.m. Eastern Daylight Time, 2 p.m. Central European Summer Time, on August 8, 2018 to discuss these financial results and provide a corporate update.

Investors may participate by dialing (844) 419-1772 for U.S. callers and +1 (213) 660-0921 for international callers, and referring to conference ID 6749875. A webcast of the conference call can be accessed under the "Investors" section of ObsEva's website www.obseva.com.

You may also be interested in